X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - DRUGS.COM - Pharma Industry News - 28/Oct 14:10

FDA Approves Tezspire for Chronic Rhinosinusitis With Nasal Polyps

TUESDAY, Oct. 28, 2025 -- The U.S. Food and Drug Administration approved Tezspire (tezepelumab-ekko; Amgen) for the add-on maintenance treatment of inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP) in adult and pediatric...

Articles similaires

Sorry! Image not available at this time

Tezspire approved in the EU for chronic rhinosinusitis with nasal polyps

wn.com - 23/Oct 10:39

Approval based on WAYPOINT Phase III results demonstrating reduced nasal polyp severity and nasal congestion, near-elimination of the need for surgery...

Sorry! Image not available at this time

FDA Approves Blenrep for Relapsed or Refractory Multiple Myeloma

drugs.com - 30/Oct 15:10

THURSDAY, Oct. 30, 2025 -- The U.S. Food and Drug Administration approved Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and...

Sorry! Image not available at this time

FDA Approves Blenrep for Relapsed or Refractory Multiple Myeloma

drugs.com - 30/Oct 15:10

THURSDAY, Oct. 30, 2025 -- The U.S. Food and Drug Administration approved Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and...

Sorry! Image not available at this time

Syndax Announces FDA Approval of Revuforj (revumenib) in Adult and Pediatric Patients with Relapsed or Refractory NPM1 Mutated Acute Myeloid Leukemia

drugs.com - 24/Oct 21:10

NEW YORK, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative...

Sorry! Image not available at this time

Syndax Announces FDA Approval of Revuforj (revumenib) in Adult and Pediatric Patients with Relapsed or Refractory NPM1 Mutated Acute Myeloid Leukemia

drugs.com - 24/Oct 21:10

NEW YORK, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative...

Sorry! Image not available at this time

Blenrep Approved by US FDA for Use in Treatment of Relapsed/Refractory Multiple Myeloma

drugs.com - 23/Oct 22:10

London, UK October 23, 2025 GSK plc (LSE/NYSE: GSK) today announced the US Food and Drug Administration (FDA) has approved Blenrep (belantamab...

Sorry! Image not available at this time

FDA Approves Contepo (fosfomycin) for Injection for the Treatment of Complicated Urinary Tract Infections

drugs.com - 22/Oct 03:10

October 22, 2025 – The U.S. Food and Drug Administration (FDA) has approved Contepo (fosfomycin) for injection for the treatment of patients 18...

Sorry! Image not available at this time

FDA Approves Contepo (fosfomycin) for Injection for the Treatment of Complicated Urinary Tract Infections

drugs.com - 22/Oct 03:10

October 22, 2025 – The U.S. Food and Drug Administration (FDA) has approved Contepo (fosfomycin) for injection for the treatment of patients 18...

Sorry! Image not available at this time

Women Have Higher Odds of Chronic Rhinosinusitis Without Nasal Polyps

drugs.com - 29/Oct 15:10

WEDNESDAY, Oct. 29, 2025 -- Females have a higher odds of chronic rhinosinusitis (CRS) without nasal polyps than men, according to a study published...

Sorry! Image not available at this time

Women Have Higher Odds of Chronic Rhinosinusitis Without Nasal Polyps

drugs.com - 29/Oct 15:10

WEDNESDAY, Oct. 29, 2025 -- Females have a higher odds of chronic rhinosinusitis (CRS) without nasal polyps than men, according to a study published...

Les derniers communiqués